fda decision on compounded tirzepatide news Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Is Tirzepatide Legal in 2026?

Compared to previous research based on other GLP-1 agonists, the data from this review underscore the superiority of semaglutide in reducing cardiovascular outcomes

Data from Dupixent clinical trials have shown that IL-4 and IL-13 are key drivers of the type 2 inflammation that plays a major role in atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP)

Comparison of the effects on glycaemic control and beta-cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel-group trial (the CONFIDENCE study) J Intern Med

This reflects both higher insulin prices and greater demand for insulin in Part D, according to the study

Lancet 1 , 785789 (1963)

Worth following if you're dealing with pediatric cases